The Epigenetics Market is expected to grow significantly, reaching $6.33 billion by 2031, with a compound annual growth rate (CAGR) of 15.7% between 2024 and 2031.
In the rapidly evolving field of cancer treatment, precision oncology is redefining how healthcare